Date: January 1, 2020Author: Nwo Report
Source: Alanna Ketler
- The Facts:There have been many therapeutic benefits of psychedelic substances discovered over the past decade for using them potentially as a medicinal tool.
- Reflect On:Considering how promising a lot of this research is, should the laws be lifted in order to make it easier for scientists to study the potential of these psychedelic substances?
Over the course of the past decade or so, the study of psychedelic substances such as psilocybin (the active ingredient in ‘magic mushrooms’), MDMA, and LSD for treatment of various mental disorders has gained a lot of traction. As the stigma lifts and the laws slowly shift it leaves the door open for further studies into the potential of some of these substances. Recently, new results have been published in one of the first placebo-controlled clinical trials examining the therapeutic benefits of Lysergic Acid Diethylamide (LSD) and whether or not it could be used as a treatment for those struggling with Alzheimer’s disease, for which there is no known cure.
advertisement – learn more
The research is still in its infancy stage, but the Phase 1 trial discussed in this article is the first step towards testing whether psychedelic microdose methods are safe enough to garner a larger study down the road with direct treatment of Alzheimer’s using microdoses of LSD.
Thanks to: https://nworeport.me